 | • レポートコード：QAF27815 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の口腔内崩壊錠用賦形剤市場について種類別（バインダー、グリデント、希釈剤、崩壊剤、その他）、用途別（抗精神病薬、抗てんかん薬、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・口腔内崩壊錠用賦形剤市場の概要 ・世界の主要地域別口腔内崩壊錠用賦形剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の口腔内崩壊錠用賦形剤市場規模2016-2021：種類別（バインダー、グリデント、希釈剤、崩壊剤、その他） ・世界の口腔内崩壊錠用賦形剤市場予測2012-2027：種類別（バインダー、グリデント、希釈剤、崩壊剤、その他） ・世界の口腔内崩壊錠用賦形剤市場規模2016-2021：用途別（抗精神病薬、抗てんかん薬、その他） ・世界の口腔内崩壊錠用賦形剤市場予測2012-2027：用途別（抗精神病薬、抗てんかん薬、その他） ・口腔内崩壊錠用賦形剤のアメリカ市場規模と予測2016-2021 ・口腔内崩壊錠用賦形剤のヨーロッパ市場規模と予測2016-2021 ・口腔内崩壊錠用賦形剤の中国市場規模と予測2016-2021 ・口腔内崩壊錠用賦形剤の日本市場規模と予測2016-2021 ・口腔内崩壊錠用賦形剤の東南アジア市場規模と予測2016-2021 ・口腔内崩壊錠用賦形剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （BASF、JRS Pharma、Roquette、ABF Ingredients、DFE Pharma、Evonik、Merck KGaA、Ashland、Meggle Pharma、Shin-Etsu、Fuji Chemical Industries、McePharma (Vivesa holding)、Cargill Incorporated、Daicel Corporation、Anhui Sunhere Pharmaceutical） ・口腔内崩壊錠用賦形剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・口腔内崩壊錠用賦形剤の市場動向・機会・課題 ・調査の結論 |
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3.5% in 2018, followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.
Market Analysis and Insights: Global Orally Disintegrating Tablet Excipient Market
The global Orally Disintegrating Tablet Excipient market was valued at US$ 16890 in 2020 and will reach US$ 20760 million by the end of 2027, growing at a CAGR of 3.5% during 2022-2027.
Global Orally Disintegrating Tablet Excipient Scope and Market Size
The global Orally Disintegrating Tablet Excipient market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orally Disintegrating Tablet Excipient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Binders had the biggest market share of 37% in 2018.
Segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.
The Orally Disintegrating Tablet Excipient market is analysed and market size information is provided by regions (countries). Segment by Application, the Orally Disintegrating Tablet Excipient market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
1 Orally Disintegrating Tablet Excipient Market Overview
1.1 Orally Disintegrating Tablet Excipient Product Scope
1.2 Orally Disintegrating Tablet Excipient Segment by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2016 & 2021 & 2027)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Orally Disintegrating Tablet Excipient Segment by Application
1.3.1 Global Orally Disintegrating Tablet Excipient Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Orally Disintegrating Tablet Excipient Market Estimates and Forecasts (2016-2027)
1.4.1 Global Orally Disintegrating Tablet Excipient Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Orally Disintegrating Tablet Excipient Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Orally Disintegrating Tablet Excipient Price Trends (2016-2027)
2 Orally Disintegrating Tablet Excipient Estimates and Forecasts by Region
2.1 Global Orally Disintegrating Tablet Excipient Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Orally Disintegrating Tablet Excipient Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2016-2021)
2.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2016-2021)
2.3 Global Orally Disintegrating Tablet Excipient Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Orally Disintegrating Tablet Excipient Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Orally Disintegrating Tablet Excipient Estimates and Projections (2016-2027)
2.4.2 Europe Orally Disintegrating Tablet Excipient Estimates and Projections (2016-2027)
2.4.3 China Orally Disintegrating Tablet Excipient Estimates and Projections (2016-2027)
2.4.4 Japan Orally Disintegrating Tablet Excipient Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Orally Disintegrating Tablet Excipient Estimates and Projections (2016-2027)
2.4.6 India Orally Disintegrating Tablet Excipient Estimates and Projections (2016-2027)
3 Global Orally Disintegrating Tablet Excipient Competition Landscape by Players
3.1 Global Top Orally Disintegrating Tablet Excipient Players by Sales (2016-2021)
3.2 Global Top Orally Disintegrating Tablet Excipient Players by Revenue (2016-2021)
3.3 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2020)
3.4 Global Orally Disintegrating Tablet Excipient Average Price by Company (2016-2021)
3.5 Manufacturers Orally Disintegrating Tablet Excipient Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Orally Disintegrating Tablet Excipient Market Size by Type
4.1 Global Orally Disintegrating Tablet Excipient Historic Market Review by Type (2016-2021)
4.1.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
4.1.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2021)
4.1.3 Global Orally Disintegrating Tablet Excipient Price by Type (2016-2021)
4.2 Global Orally Disintegrating Tablet Excipient Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2022-2027)
4.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2022-2027)
4.2.3 Global Orally Disintegrating Tablet Excipient Price Forecast by Type (2022-2027)
5 Global Orally Disintegrating Tablet Excipient Market Size by Application
5.1 Global Orally Disintegrating Tablet Excipient Historic Market Review by Application (2016-2021)
5.1.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
5.1.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2021)
5.1.3 Global Orally Disintegrating Tablet Excipient Price by Application (2016-2021)
5.2 Global Orally Disintegrating Tablet Excipient Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2022-2027)
5.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Application (2022-2027)
5.2.3 Global Orally Disintegrating Tablet Excipient Price Forecast by Application (2022-2027)
6 North America Orally Disintegrating Tablet Excipient Market Facts & Figures
6.1 North America Orally Disintegrating Tablet Excipient Sales by Company
6.1.1 North America Orally Disintegrating Tablet Excipient Sales by Company (2016-2021)
6.1.2 North America Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021)
6.2 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Type
6.2.1 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2016-2021)
6.2.2 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2022-2027)
6.3 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Application
6.3.1 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2016-2021)
6.3.2 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2022-2027)
7 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures
7.1 Europe Orally Disintegrating Tablet Excipient Sales by Company
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Company (2016-2021)
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021)
7.2 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Type
7.2.1 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2016-2021)
7.2.2 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2022-2027)
7.3 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Orally Disintegrating Tablet Excipient Market Facts & Figures
8.1 China Orally Disintegrating Tablet Excipient Sales by Company
8.1.1 China Orally Disintegrating Tablet Excipient Sales by Company (2016-2021)
8.1.2 China Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021)
8.2 China Orally Disintegrating Tablet Excipient Sales Breakdown by Type
8.2.1 China Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2016-2021)
8.2.2 China Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2022-2027)
8.3 China Orally Disintegrating Tablet Excipient Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Orally Disintegrating Tablet Excipient Market Facts & Figures
9.1 Japan Orally Disintegrating Tablet Excipient Sales by Company
9.1.1 Japan Orally Disintegrating Tablet Excipient Sales by Company (2016-2021)
9.1.2 Japan Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021)
9.2 Japan Orally Disintegrating Tablet Excipient Sales Breakdown by Type
9.2.1 Japan Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2016-2021)
9.2.2 Japan Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2022-2027)
9.3 Japan Orally Disintegrating Tablet Excipient Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Orally Disintegrating Tablet Excipient Market Facts & Figures
10.1 Southeast Asia Orally Disintegrating Tablet Excipient Sales by Company
10.1.1 Southeast Asia Orally Disintegrating Tablet Excipient Sales by Company (2016-2021)
10.1.2 Southeast Asia Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021)
10.2 Southeast Asia Orally Disintegrating Tablet Excipient Sales Breakdown by Type
10.2.1 Southeast Asia Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Orally Disintegrating Tablet Excipient Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Orally Disintegrating Tablet Excipient Market Facts & Figures
11.1 India Orally Disintegrating Tablet Excipient Sales by Company
11.1.1 India Orally Disintegrating Tablet Excipient Sales by Company (2016-2021)
11.1.2 India Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021)
11.2 India Orally Disintegrating Tablet Excipient Sales Breakdown by Type
11.2.1 India Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2016-2021)
11.2.2 India Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2022-2027)
11.3 India Orally Disintegrating Tablet Excipient Sales Breakdown by Application
11.3.1 India Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2016-2021)
11.3.2 India Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Orally Disintegrating Tablet Excipient Business
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Business Overview
12.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.1.4 BASF Orally Disintegrating Tablet Excipient Products Offered
12.1.5 BASF Recent Development
12.2 JRS Pharma
12.2.1 JRS Pharma Corporation Information
12.2.2 JRS Pharma Business Overview
12.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
12.2.5 JRS Pharma Recent Development
12.3 Roquette
12.3.1 Roquette Corporation Information
12.3.2 Roquette Business Overview
12.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roquette Orally Disintegrating Tablet Excipient Products Offered
12.3.5 Roquette Recent Development
12.4 ABF Ingredients
12.4.1 ABF Ingredients Corporation Information
12.4.2 ABF Ingredients Business Overview
12.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
12.4.5 ABF Ingredients Recent Development
12.5 DFE Pharma
12.5.1 DFE Pharma Corporation Information
12.5.2 DFE Pharma Business Overview
12.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
12.5.5 DFE Pharma Recent Development
12.6 Evonik
12.6.1 Evonik Corporation Information
12.6.2 Evonik Business Overview
12.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Evonik Orally Disintegrating Tablet Excipient Products Offered
12.6.5 Evonik Recent Development
12.7 Merck KGaA
12.7.1 Merck KGaA Corporation Information
12.7.2 Merck KGaA Business Overview
12.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
12.7.5 Merck KGaA Recent Development
12.8 Ashland
12.8.1 Ashland Corporation Information
12.8.2 Ashland Business Overview
12.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Ashland Orally Disintegrating Tablet Excipient Products Offered
12.8.5 Ashland Recent Development
12.9 Meggle Pharma
12.9.1 Meggle Pharma Corporation Information
12.9.2 Meggle Pharma Business Overview
12.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
12.9.5 Meggle Pharma Recent Development
12.10 Shin-Etsu
12.10.1 Shin-Etsu Corporation Information
12.10.2 Shin-Etsu Business Overview
12.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
12.10.5 Shin-Etsu Recent Development
12.11 Fuji Chemical Industries
12.11.1 Fuji Chemical Industries Corporation Information
12.11.2 Fuji Chemical Industries Business Overview
12.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Products Offered
12.11.5 Fuji Chemical Industries Recent Development
12.12 McePharma (Vivesa holding)
12.12.1 McePharma (Vivesa holding) Corporation Information
12.12.2 McePharma (Vivesa holding) Business Overview
12.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Products Offered
12.12.5 McePharma (Vivesa holding) Recent Development
12.13 Cargill Incorporated
12.13.1 Cargill Incorporated Corporation Information
12.13.2 Cargill Incorporated Business Overview
12.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Products Offered
12.13.5 Cargill Incorporated Recent Development
12.14 Daicel Corporation
12.14.1 Daicel Corporation Corporation Information
12.14.2 Daicel Corporation Business Overview
12.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Products Offered
12.14.5 Daicel Corporation Recent Development
12.15 Anhui Sunhere Pharmaceutical
12.15.1 Anhui Sunhere Pharmaceutical Corporation Information
12.15.2 Anhui Sunhere Pharmaceutical Business Overview
12.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Products Offered
12.15.5 Anhui Sunhere Pharmaceutical Recent Development
13 Orally Disintegrating Tablet Excipient Manufacturing Cost Analysis
13.1 Orally Disintegrating Tablet Excipient Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
13.4 Orally Disintegrating Tablet Excipient Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Orally Disintegrating Tablet Excipient Distributors List
14.3 Orally Disintegrating Tablet Excipient Customers
15 Market Dynamics
15.1 Orally Disintegrating Tablet Excipient Market Trends
15.2 Orally Disintegrating Tablet Excipient Drivers
15.3 Orally Disintegrating Tablet Excipient Market Challenges
15.4 Orally Disintegrating Tablet Excipient Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Orally Disintegrating Tablet Excipient Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Orally Disintegrating Tablet Excipient Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Orally Disintegrating Tablet Excipient Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Region (2016-2021)
Table 5. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2016-2021)
Table 6. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Orally Disintegrating Tablet Excipient Revenue Share by Region (2016-2021)
Table 8. Global Orally Disintegrating Tablet Excipient Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Orally Disintegrating Tablet Excipient Revenue Share Forecast by Region (2022-2027)
Table 12. Global Orally Disintegrating Tablet Excipient Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Orally Disintegrating Tablet Excipient Sales Share by Company (2016-2021)
Table 14. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Orally Disintegrating Tablet Excipient Revenue Share by Company (2016-2021)
Table 16. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2020)
Table 17. Global Orally Disintegrating Tablet Excipient Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Orally Disintegrating Tablet Excipient Manufacturing Sites and Area Served
Table 19. Manufacturers Orally Disintegrating Tablet Excipient Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2016-2021)
Table 22. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2016-2021)
Table 23. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2016-2021)
Table 25. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2022-2027)
Table 26. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2022-2027)
Table 28. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2022-2027)
Table 29. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2016-2021)
Table 30. Global Orally Disintegrating Tablet Excipient Sales Share by Application (2016-2021)
Table 31. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2016-2021)
Table 33. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2022-2027)
Table 34. Global Orally Disintegrating Tablet Excipient Sales Share by Application (2022-2027)
Table 35. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Orally Disintegrating Tablet Excipient Revenue Share by Application (2022-2027)
Table 37. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2022-2027)
Table 38. North America Orally Disintegrating Tablet Excipient Sales (K MT) by Company (2016-2021)
Table 39. North America Orally Disintegrating Tablet Excipient Sales Market Share by Company (2016-2021)
Table 40. North America Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2016-2021)
Table 42. North America Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 43. North America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 44. North America Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
Table 45. North America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2022-2027)
Table 46. North America Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 47. North America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 48. North America Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
Table 49. North America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2022-2027)
Table 50. Europe Orally Disintegrating Tablet Excipient Sales (K MT) by Company (2016-2021)
Table 51. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Company (2016-2021)
Table 52. Europe Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2016-2021)
Table 54. Europe Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 55. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 56. Europe Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
Table 57. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2022-2027)
Table 58. Europe Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 59. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 60. Europe Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
Table 61. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2022-2027)
Table 62. China Orally Disintegrating Tablet Excipient Sales (K MT) by Company (2016-2021)
Table 63. China Orally Disintegrating Tablet Excipient Sales Market Share by Company (2016-2021)
Table 64. China Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2016-2021)
Table 66. China Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 67. China Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 68. China Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
Table 69. China Orally Disintegrating Tablet Excipient Sales Market Share by Type (2022-2027)
Table 70. China Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 71. China Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 72. China Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
Table 73. China Orally Disintegrating Tablet Excipient Sales Market Share by Application (2022-2027)
Table 74. Japan Orally Disintegrating Tablet Excipient Sales (K MT) by Company (2016-2021)
Table 75. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Company (2016-2021)
Table 76. Japan Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2016-2021)
Table 78. Japan Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 79. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 80. Japan Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
Table 81. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Type (2022-2027)
Table 82. Japan Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 83. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 84. Japan Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
Table 85. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Orally Disintegrating Tablet Excipient Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Application (2022-2027)
Table 98. India Orally Disintegrating Tablet Excipient Sales (K MT) by Company (2016-2021)
Table 99. India Orally Disintegrating Tablet Excipient Sales Market Share by Company (2016-2021)
Table 100. India Orally Disintegrating Tablet Excipient Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2016-2021)
Table 102. India Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 103. India Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 104. India Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
Table 105. India Orally Disintegrating Tablet Excipient Sales Market Share by Type (2022-2027)
Table 106. India Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 107. India Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 108. India Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
Table 109. India Orally Disintegrating Tablet Excipient Sales Market Share by Application (2022-2027)
Table 110. BASF Corporation Information
Table 111. BASF Description and Business Overview
Table 112. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. BASF Orally Disintegrating Tablet Excipient Product
Table 114. BASF Recent Development
Table 115. JRS Pharma Corporation Information
Table 116. JRS Pharma Description and Business Overview
Table 117. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. JRS Pharma Orally Disintegrating Tablet Excipient Product
Table 119. JRS Pharma Recent Development
Table 120. Roquette Corporation Information
Table 121. Roquette Description and Business Overview
Table 122. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Roquette Orally Disintegrating Tablet Excipient Product
Table 124. Roquette Recent Development
Table 125. ABF Ingredients Corporation Information
Table 126. ABF Ingredients Description and Business Overview
Table 127. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. ABF Ingredients Orally Disintegrating Tablet Excipient Product
Table 129. ABF Ingredients Recent Development
Table 130. DFE Pharma Corporation Information
Table 131. DFE Pharma Description and Business Overview
Table 132. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. DFE Pharma Orally Disintegrating Tablet Excipient Product
Table 134. DFE Pharma Recent Development
Table 135. Evonik Corporation Information
Table 136. Evonik Description and Business Overview
Table 137. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Evonik Orally Disintegrating Tablet Excipient Product
Table 139. Evonik Recent Development
Table 140. Merck KGaA Corporation Information
Table 141. Merck KGaA Description and Business Overview
Table 142. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Merck KGaA Orally Disintegrating Tablet Excipient Product
Table 144. Merck KGaA Recent Development
Table 145. Ashland Corporation Information
Table 146. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Ashland Description and Business Overview
Table 148. Ashland Orally Disintegrating Tablet Excipient Product
Table 149. Ashland Recent Development
Table 150. Meggle Pharma Corporation Information
Table 151. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Meggle Pharma Description and Business Overview
Table 153. Meggle Pharma Orally Disintegrating Tablet Excipient Product
Table 154. Meggle Pharma Recent Development
Table 155. Shin-Etsu Corporation Information
Table 156. Shin-Etsu Description and Business Overview
Table 157. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Shin-Etsu Orally Disintegrating Tablet Excipient Product
Table 159. Shin-Etsu Recent Development
Table 160. Fuji Chemical Industries Corporation Information
Table 161. Fuji Chemical Industries Description and Business Overview
Table 162. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product
Table 164. Fuji Chemical Industries Recent Development
Table 165. McePharma (Vivesa holding) Corporation Information
Table 166. McePharma (Vivesa holding) Description and Business Overview
Table 167. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product
Table 169. McePharma (Vivesa holding) Recent Development
Table 170. Cargill Incorporated Corporation Information
Table 171. Cargill Incorporated Description and Business Overview
Table 172. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Cargill Incorporated Orally Disintegrating Tablet Excipient Product
Table 174. Cargill Incorporated Recent Development
Table 175. Daicel Corporation Corporation Information
Table 176. Daicel Corporation Description and Business Overview
Table 177. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Daicel Corporation Orally Disintegrating Tablet Excipient Product
Table 179. Daicel Corporation Recent Development
Table 180. Anhui Sunhere Pharmaceutical Corporation Information
Table 181. Anhui Sunhere Pharmaceutical Description and Business Overview
Table 182. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product
Table 184. Anhui Sunhere Pharmaceutical Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Orally Disintegrating Tablet Excipient Distributors List
Table 188. Orally Disintegrating Tablet Excipient Customers List
Table 189. Orally Disintegrating Tablet Excipient Market Trends
Table 190. Orally Disintegrating Tablet Excipient Market Drivers
Table 191. Orally Disintegrating Tablet Excipient Market Challenges
Table 192. Orally Disintegrating Tablet Excipient Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Orally Disintegrating Tablet Excipient Product Picture
Figure 2. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2021 & 2027
Figure 6. Anti-Psychotics Drug Examples
Figure 7. Anti-Epileptics Drug Examples
Figure 8. Others Examples
Figure 9. Global Orally Disintegrating Tablet Excipient Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Orally Disintegrating Tablet Excipient Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Orally Disintegrating Tablet Excipient Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Orally Disintegrating Tablet Excipient Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Orally Disintegrating Tablet Excipient Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Orally Disintegrating Tablet Excipient Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Orally Disintegrating Tablet Excipient Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Orally Disintegrating Tablet Excipient Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Orally Disintegrating Tablet Excipient Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Orally Disintegrating Tablet Excipient Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Orally Disintegrating Tablet Excipient Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Orally Disintegrating Tablet Excipient Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Orally Disintegrating Tablet Excipient Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Orally Disintegrating Tablet Excipient Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Orally Disintegrating Tablet Excipient Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Orally Disintegrating Tablet Excipient Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Orally Disintegrating Tablet Excipient Players Market Share by Revenue in Orally Disintegrating Tablet Excipient: 2016 & 2020
Figure 28. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2016-2021)
Figure 30. Global Orally Disintegrating Tablet Excipient Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Orally Disintegrating Tablet Excipient Revenue Share by Application (2016-2021)
Figure 32. Global Orally Disintegrating Tablet Excipient Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 34. North America Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 35. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 36. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 37. China Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 38. China Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 39. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 40. Japan Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 41. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 42. Southeast Asia Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 43. India Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 44. India Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Orally Disintegrating Tablet Excipient
Figure 47. Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
Figure 48. Orally Disintegrating Tablet Excipient Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の口腔内崩壊錠賦形剤産業調査2019-2025 Orally disintegrating tablets (ODTs), also known as orodispersible tablets, are unique dosage forms formulated to improve their in vivo disintegration and dissolution rates. It is a big challenge to ODT producers to achieve a minimum disintegration time while keeping formulation simple and robust.Th…- 世界の口腔内崩壊錠賦形剤産業調査2019-2025 Orally disintegrating tablets (ODTs), also known as orodispersible tablets, are unique dosage forms formulated to improve their in vivo disintegration and dissolution rates. It is a big challenge to ODT producers to achieve a minimum disintegration time while keeping formulation simple and robust.Th…
- アルブミン（賦形剤）のグローバル市場2021 Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare di…
- ペンタブレットのグローバル市場2021 A pen tablet (also known as a digitizer, drawing tablet, digital drawing tablet, graphic tablet, or digital art board) is a computer input device that enables a user to hand-draw images, animations and graphics, with a special pen-like stylus, similar to the way a person draws images with a pencil a…
- アルテスネイト錠剤のグローバル市場2021 Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. The classification of Artesunate Tablet includes Monoaromatic Artesunate and Compou…